Corbus Pharmaceuticals Holdings, Inc. (CRBP) Shareholders’ equity 2016–2022
Corbus Pharmaceuticals Holdings, Inc. (CRBP) shareholders’ equity at each fiscal year-end, per SEC filings.
$33.0MFY2022 · since FY2016: $8.9M → $33.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $33.0M | -52.3% |
| FY2021 | $69.1M | +52.6% |
| FY2020 | $45.3M | +635.3% |
| FY2019 | $6.2M | -77.6% |
| FY2018 | $27.5M | -52.4% |
| FY2017 | $57.8M | +547.9% |
| FY2016 | $8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice